Novartis’ Zausner named HBA Woman of the Year

Share this article:
Novartis’ Oncology’s Meryl Zausner has been named as The Healthcare Businesswomen’s Association’s 2007 Woman of the Year. Zausner is VP and CFO at Novartis Oncology, of which she is a founding member. Novartis Oncology launched in 2000 and now boasts more than 4,000 employees and $6 billion in sales. Zausner’s boss, Novartis Oncology president and CEO David Epstein, was the HBA’s 2004 honorable mentor. Epstein called her “a truly unique and exceptional business leader. She is tough on business by caring and compassionate about people.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...